Drug & Medical Device Litigation

Wednesday, December 12, 2007
THE FOOD & DRUG ADMINISTRATION AMENDMENTS ACT OF 2007: LIABILITY & ENFORCEMENT IMPLICATIONS FOR INDUSTRY
Steven E. Irizarry, Capitol Hill Consulting Group (Washington, DC)

STATES’ TORT REFORMS: WHERE WE HAVE BEEN AND WHERE WE MAY BE GOING…
Cynthia Day Grimes, Ball & Weed, P.C. (San Antonio, TX)

STATE FARM AT FIVE: PRESERVING A PUNITIVE DAMAGES CHALLENGE
Diane E. Lifton, Gibbons P.C. (Newark, NJ)

LITIGATING THE PREEMPTION DEFENSE: PICKING YOUR FIGHTS CAREFULLY
Anand Agneshwar, Arnold & Porter LLP (New York, NY)
Michael X. Imbroscio, Covington & Burling LLP (Washington, DC)
Lisa Martinez Wolmart, Esq., Schering-Plough Corporation (Kenilworth, NJ)

BEYOND PREEMPTION: NAVIGATING YOUR WAY THROUGH THE CRUCIAL FDA REGULATORY MAZE WHEN STRUCTURING A PRODUCTS LIABILITY DEFENSE
Howard L. Dorfman, Bayer HealthCare LLC (West Haven, CT)

BEYOND PREEMPTION: NAVIGATING YOUR WAY THROUGH THE CRUCIAL FDA REGULATORY MAZE WHEN STRUCTURING A PRODUCTS LIABILITY DEFENSE
Ellen Reisman, Arnold & Porter LLP (Los Angeles, CA)

LABELING: THE ATTACKS AND DEFENSES
Diane P. Sullivan, Dechert LLP (Princeton, NJ)

THE CURRENT MDL AND CLASS ACTION LANDSCAPE: COORDINATION AND OTHER WINNING STRATEGIES FOR LITIGATION IN MULTIPLE JURISDICTIONS
Dan Dunham, Pfizer Inc. (New York, NY)

THE MDL LANDSCAPE
Mark Herrmann, Jones Day (Chicago, IL)

ASYMMETRICAL DISCOVERY IN MULTI-DISTRICT LITIGATION
Stephen J. McConnell, Dechert LLP (Philadelphia, PA)

CONGRESSIONAL AND OTHER GOVERNMENT INVESTIGATIONS OF MARKETING PRACTICES: ASSESSING THE PRODUCTS LIABILITY IMPACT AND THE USE OF PRIVILEGE
Rachel Abramovitz, Taro Pharmaceuticals U.S.A., Inc. (Hawthorne, NY)
George J. Lykos, Bayer Corporation (Pittsburgh, PA)
Wendy H. Schwartz, Reed Smith LLP (New York, NY)
Andrew T. Bayman, King & Spalding (Atlanta, GA)

JURY COMMUNICATION: CHANGING PERCEPTIONS OF THE INDUSTRY/FDA
Gil Calvillo, Ph.D., FTI Consulting (Los Angeles, CA)
Harvey L. Kaplan, Shook, Hardy & Bacon L.L.P. (Kansas City, MO)
Eric M. Kraus, Sedgwick, Detert, Moran & Arnold LLP (New York, NY)

THE ENDGAME: CLAIMS ADMINISTRATION
James White, Rust Consulting, Inc. (Minneapolis, MN)

WHAT THE CLIENT NEEDS
James J. Dillon, Foley Hoag LLP (Boston, MA) A CASE STUDY IN “SWIFT AND CONSTANT ATTACKS BY AN ACADEMIC/SCIENTIFIC SOURCE”
Paul E. Benson, Michael Best & Friedrich LLP (Milwaukee, WI)

SWIFT AND CONSTANT ATTACKS BY THE PRESS AND ACADEMIC/SCIENTIFIC SOURCES: PINPOINTING THEIR IMPACT ON LITIGATION AND LEARNING HOW TO COMBAT AND CONTROL THEM
José A. Isasi, II, Greenberg Traurig, LLP (Chicago, IL)

SELECTED ISSUES IN CHALLENGING PLAINTIFF’S EXPERTS
Ronn B. Kreps, Fulbright & Jaworski L.L.P. (Minneapolis, MN)

DAUBERT UPDATES
Andrea Roberts, Baker & Daniels LLP (Indianapolis, IN)

DAUBERT CHALLENGES TO CAUSATION EXPERT TESTIMONY
Sean P. Wajert, Dechert LLP (Philadelphia, PA)

THE IMPACT OF DIRECT-TO-CONSUMER ADVERTISING ON THE CONTINUED VIABILITY OF THE LEARNED INTERMEDIARY DOCTRINE: IT’S NOT QUITE DEAD YET
Steven J. Ellison, Faegre & Benson LLP (Minneapolis, MN)

OFF-LABEL PROMOTION: PERILS AND PITFALLS
Steven G. Reade, Arnold & Porter LLP (Washington, DC)

INSULATING YOUR SALES FORCE FROM SCRUTINY AND MANAGING PRODUCTS LIABILITY RISKS BASED ON OFF-LABEL USES: OVERVIEW
Peter V. Rother, AGA Medical Corporation (Plymouth, MN)

COMPLIANCE ISSUES FOR DEVICE COMPANIES
Sue Seferian, Johnson & Johnson (New Brunswick, NJ)

STOPPING LOOSE LIPS
J. Stephen Bennett, Baker & Daniels LLP (Fort Wayne, IN)

THE CONFIDENTIALITY STIPULATION AND ORDER: AN ENDANGERED SPECIES?
John P. Lavelle, Jr., Ballard Spahr Andrews & Ingersoll, LLP (Philadelphia, PA)

COMPANY CONFIDENTIALITY ISSUES
David N. Royster, Zimmer, Inc. (Warsaw, IN)

CONSUMER FRAUD CLAIMS AND CLASS ACTIONS
Mark S. Cheffo, Skadden, Arps, Slate, Meagher & Flom LLP (New York, NY)

CONSUMER FRAUD CLASS ACTIONS: KEY MANAGEMENT ISSUES
Christopher C. Palermo, Kelley Drye & Warren LLP (New York, NY)
Beth Trent, Schering-Plough Corporation (Kenilworth, NJ)

CONSUMER FRAUD CLAIMS AND CLASS ACTIONS: DEFENDING DRUG AND DEVICE MANUFACTURERS AT EVERY STAGE OF THE LITIGATION
Fred A. Kelly, Jr., Nixon Peabody LLP (Boston, MA)

INTERNATIONAL STRATEGIES ON MANAGING GLOBAL PRODUCTS LIABILITY RISK
James W. A. Ladner, St. Jude Medical, Inc. (St. Paul, MN)

CLASS ACTIONS IN EUROPE
Paul Llewellyn, Reed Smith LLP (Birmingham, UK)

THE THREAT OF MASS TORT PRODUCTS CLAIMS FILED BY FOREIGN CITIZENS IN U.S. COURTS
Joseph J. Ortego, Nixon Peabody LLP (New York, NY)



DOCUMENT TYPES: PRESENTATIONS AVAILABLE: 0